PROCEPT BioRobotics (PRCT) Revenue & Revenue Breakdown
PROCEPT BioRobotics Revenue Highlights
Latest Revenue (Y)
$224.50M
Latest Revenue (Q)
$69.16M
Main Geography (Y)
UNITED STATES
PROCEPT BioRobotics Revenue by Period
PROCEPT BioRobotics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $224.50M | 64.84% |
| 2023-12-31 | $136.19M | 81.55% |
| 2022-12-31 | $75.01M | 117.60% |
| 2021-12-31 | $34.47M | 346.72% |
| 2020-12-31 | $7.72M | 25.09% |
| 2019-12-31 | $6.17M | - |
PROCEPT BioRobotics generated $224.50M in revenue during NA 2024, up 64.84% compared to the previous quarter, and up 3639.13% compared to the same period a year ago.
PROCEPT BioRobotics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $69.16M | 1.36% |
| 2024-12-31 | $68.24M | 16.90% |
| 2024-09-30 | $58.37M | 9.40% |
| 2024-06-30 | $53.35M | 19.79% |
| 2024-03-31 | $44.54M | 2.20% |
| 2023-12-31 | $43.58M | 24.16% |
| 2023-09-30 | $35.10M | 6.04% |
| 2023-06-30 | $33.10M | 35.65% |
| 2023-03-31 | $24.40M | 2.64% |
| 2022-12-31 | $23.78M | 16.85% |
| 2022-09-30 | $20.35M | 21.92% |
| 2022-06-30 | $16.69M | 17.57% |
| 2022-03-31 | $14.20M | 40.04% |
| 2021-12-31 | $10.14M | 16.96% |
| 2021-09-30 | $8.67M | 2.27% |
| 2021-06-30 | $8.48M | 17.85% |
| 2021-03-31 | $7.19M | 123.28% |
| 2020-12-31 | $3.22M | 52.87% |
| 2020-09-30 | $2.11M | 76.39% |
| 2020-06-30 | $1.19M | - |
| 2020-03-31 | $1.19M | - |
PROCEPT BioRobotics generated $69.16M in revenue during Q1 2025, up 1.36% compared to the previous quarter, and up 158.70% compared to the same period a year ago.
PROCEPT BioRobotics Revenue Breakdown
PROCEPT BioRobotics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Outside the United States | $24.03M | $11.89M | $3.20M | $2.49M |
| UNITED STATES | $200.47M | $124.30M | $36.53M | $19.38M |
Latest
PROCEPT BioRobotics's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (89.30%), and Outside the United States (10.70%).
Quarterly Revenue by Country
| Country | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outside the United States | $8.87M | $7.85M | $6.16M | $5.68M | $4.34M | $6.05M | $2.78M | $1.60M | $1.47M | $848.00K | $743.00K | $869.00K | $742.00K | $768.00K | $481.00K |
| UNITED STATES | $60.29M | $60.39M | $52.22M | $47.67M | $40.20M | $68.37M | $32.33M | $14.83M | $8.77M | $10.45M | $9.81M | $8.52M | $7.75M | $5.01M | $5.04M |
Latest
PROCEPT BioRobotics's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (87.18%), and Outside the United States (12.82%).
PROCEPT BioRobotics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.72B | $437.39M |
| CNMD | CONMED | $1.31B | $321.26M |
| LIVN | LivaNova | $1.25B | $321.80M |
| FNA | Paragon 28 | $256.18M | $61.02M |
| PRCT | PROCEPT BioRobotics | $224.50M | $69.16M |
| TMCI | Treace Medical Concepts | $209.36M | $68.71M |
| KIDS | OrthoPediatrics | $204.73M | $52.67M |
| AXGN | AxoGen | $187.34M | $49.41M |
| SIBN | SI-BONE | $167.18M | $49.00M |
| ESTA | Establishment Labs | $166.03M | $44.51M |
| RXST | RxSight | $139.93M | $40.21M |
| SRDX | Surmodics | $126.08M | $28.09M |
| LUNG | Pulmonx | $83.79M | $22.54M |
| NPCE | NeuroPace | $79.91M | $21.47M |
| SGHT | Sight Sciences | $79.87M | $19.07M |
| OFIX | Orthofix Medical | - | $215.66M |